Preliminary experiments suggest conolidine may well inhibit specific ion channels, minimizing neuronal excitability and restricting discomfort signals. This mechanism is particularly pertinent in neuropathic suffering, where by irregular signaling leads to persistent pain. On top of that, conolidine seems to affect G protein-coupled receptor (GPCR)